Tech Company Financing Transactions
Acousia Therapeutics Funding Round
Acousia Therapeutics, operating out of Tübingen, secured investment capital from Esperante Ventures.
Transaction Overview
Company Name
Announced On
1/10/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to boost the progress of its Kv7.4 activator programs, with a focus on advancing the ongoing clinical development of ACOU085.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Sindelfinger Straße 3
Tübingen, 72070
Germany
Tübingen, 72070
Germany
Phone
Undisclosed
Website
Email Address
Overview
Acousia is committed to identifying and developing novel compounds (small molecules) to preserve and enhance natural hearing for patients suffering from sensorineural hearing loss (SNHL), which make up over 90 percent of those affected by hearing loss. The company aims to make hearing loss treatable for the growing number of people affected so they can stay connected and fully participate in life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Boelke
VP - Bus. Development
Jonas Dyhrfjeld-Johnsen
Browse more venture capital transactions:
Prev: 1/10/2024: Peerlogic venture capital transaction
Next: 1/10/2024: Allied Payment Network venture capital transaction
Share this article
About Database of VC Transactions
We document tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs